Stirling, UK – 13th June 2025 – Symbiosis Pharmaceutical Services (Symbiosis), a global contract manufacturing organisation (CMO) specialising in sterile manufa...

A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some are also seriously thinking abo...

The pharma giant entered an exclusive agreement with the Chinese biotech to gain rights to a cancer bispecific drug candidate. Pfizer announced Monday that it wil...

Together, the companies will produce Kaida’s KAD101 to treat uterine cancer. Northway Biotech, an end-to-end CDMO, and Kaida BioPharma, an early-stage pharma comp...

Life-changing interventions that have previously been pipedreams are now within reach for the biopharma industry, made possible through an increasingly sophistic...

The biopharma industry – long a powerhouse of scientific innovation – now stands at a critical inflection point. We are delivering breakthroughs once unimaginable, y...

Almac Group, the global contract pharmaceutical development and manufacturing organisation, has today announced its highest ever revenue, profit and employee numbers...

First clinical batches of ProtheraCytes® planned for 2026 CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, has chosen CELLfo...

The drumbeat of AI advancements over the last year has left us all breathless, wondering which benchmark will be broken next and which new problems we can solve in b...

As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are targeting the next goalpost: a cure. Sinc...